Alnylam Pharmaceuticals, Inc. (LON: 0HD2)
London flag London · Delayed Price · Currency is GBP · Price in USD
238.33
-6.27 (-2.56%)
Dec 23, 2024, 6:17 PM BST

Alnylam Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Cash & Equivalents
1,100812.69866.39819.98496.58547.18
Upgrade
Short-Term Investments
1,6801,6271,3261,6161,378988.98
Upgrade
Cash & Short-Term Investments
2,7802,4392,1922,4361,8741,536
Upgrade
Cash Growth
15.54%11.27%-9.98%29.94%22.02%41.69%
Upgrade
Accounts Receivable
353.85327.79237.96198.57102.4143.01
Upgrade
Other Receivables
----500-
Upgrade
Receivables
353.85327.79237.96198.57602.4143.01
Upgrade
Inventory
75.9989.15128.9686.3675.256.35
Upgrade
Prepaid Expenses
145.35126.38132.9288.0862.7780.34
Upgrade
Total Current Assets
3,3552,9832,6922,8092,6151,716
Upgrade
Property, Plant & Equipment
703.41725.79738.63733.63706.51646.38
Upgrade
Other Long-Term Assets
146.21121.39115.48101.185.7732.89
Upgrade
Total Assets
4,2053,8303,5463,6433,4072,395
Upgrade
Accounts Payable
70.8155.5298.0973.4351.9749.88
Upgrade
Accrued Expenses
946.17654.73513.78372.33299.27176.58
Upgrade
Current Portion of Long-Term Debt
90.5254.9940.2937.0813.32-
Upgrade
Current Portion of Leases
42.1441.5141.9740.5536.8727.69
Upgrade
Current Unearned Revenue
71.03102.7542.11149.48127.2177.82
Upgrade
Other Current Liabilities
-58.2831.6822.8456.6420.62
Upgrade
Total Current Liabilities
1,221967.79767.92695.71585.27352.59
Upgrade
Long-Term Debt
2,3582,3432,2691,8271,250-
Upgrade
Long-Term Leases
236.03243.1261.34281.35293.04276.14
Upgrade
Long-Term Unearned Revenue
1.01188.18193.79152.36225.09318.38
Upgrade
Other Long-Term Liabilities
357.48308.44212.5898.9632.715.03
Upgrade
Total Liabilities
4,1734,0513,7053,0552,391956.44
Upgrade
Common Stock
1.291.261.241.21.161.12
Upgrade
Additional Paid-In Capital
7,2606,8116,4556,0585,6445,201
Upgrade
Retained Earnings
-7,204-7,010-6,569-5,438-4,585-3,727
Upgrade
Comprehensive Income & Other
-24.83-23.38-44.65-33.26-43.62-36.52
Upgrade
Shareholders' Equity
32.35-220.64-158.22588.21,0161,439
Upgrade
Total Liabilities & Equity
4,2053,8303,5463,6433,4072,395
Upgrade
Total Debt
2,7262,6832,6132,1861,593303.82
Upgrade
Net Cash (Debt)
54.04-243.24-420.15249.87281.671,232
Upgrade
Net Cash Growth
----11.29%-77.14%16.90%
Upgrade
Net Cash Per Share
0.43-1.95-3.452.112.4511.28
Upgrade
Filing Date Shares Outstanding
128.98125.95124.13120.21117112.58
Upgrade
Total Common Shares Outstanding
128.84125.79123.93120.18116.43112.19
Upgrade
Working Capital
2,1352,0151,9242,1132,0301,363
Upgrade
Book Value Per Share
0.25-1.75-1.284.898.7312.82
Upgrade
Tangible Book Value
32.35-220.64-158.22588.21,0161,439
Upgrade
Tangible Book Value Per Share
0.25-1.75-1.284.898.7312.82
Upgrade
Land
-9.089.089.089.089.08
Upgrade
Buildings
-271.65269.32262.64262.64250.38
Upgrade
Machinery
-202.89173.1137.86120.1555.05
Upgrade
Construction In Progress
-30.114.680.7528.0154.2
Upgrade
Leasehold Improvements
-235.41230.85152.05149.51132.63
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.